Fosun, Shanghai Pharma bid for KKR-backed Arbor, deal may fetch $700m

A company logo of Fosun International is seen during the annual general meeting of the Chinese conglomerate, founded by billionaire Guo Guangchang, in Hong Kong, China May 28, 2015. REUTERS/Bobby Yip

Fosun International Ltd.’s health-care business and Shanghai Pharmaceuticals Holding Co. are among bidders for a stake in U.S. specialty drugmaker Arbor Pharmaceuticals LLC, according to people with knowledge of the matter.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe